Taken together, our findings highlight the significance of IQGAP1 in HBV-mediated HCC progression and implicate IQGAP1 as a promising biomarker for the individualised management of patients with HBV-associated HCC. The gene discussed is IQGAP1; the disease is hepatocellular carcinoma.